Role of 18F-FDG PET/CT Concurrent with First 131I Therapy in High-Risk Differentiated Thyroid Cancer Patients: Preliminary Results.
Thyroid World Congress ePoster Library. Rizzo A. 06/22/19; 272044; 115
Alessio Rizzo
Alessio Rizzo
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

BACKGROUND: ATA Guidelines for adult patients with differentiated thyroid cancer1 (DTC) defined 4 categories to classify radioiodine-refractory patients. 2 out of 4 categories are: presence of metastatic tissue which does not concentrate RAI at the first therapeutic whole-body scan (TxWBS); uptake of radioiodine in some lesions but not in others. Aim of the present study was to evaluate the performance 18F-FDG PET/CT concurrent with first radioiodine therapy (RAI) in high risk differentiated thyroid cancer (DTC) patients to predict radioiodine-refractory DTC distant metastases.



METHODS: We prospectively selected patients classified as high risk by ATA 2015 Risk Stratification System1, submitted to total thyroidectomy and first RAI treatment. 13 patients, off L-T4, were submitted to PET/CT 3 months after surgery and within 1 week from RAI. The analysis of PET/CT and TxWBS images was performed only on distant metastases. Semi-quantitative analysis [standard uptake value (SUV), qPET, metabolic tumor volume (MTV) and total lesion glycolysis (TLG)] was performed on PET/CT target lesions (hottest lesion for each organ). ROC curve analysis was used to identify a potential cut-off for semi-quantitative parameters to predict radioiodine uptake.



RESULTS: To semi-quantitative PET/CT analysis, target lesions with no radioiodine uptake, showed a value of SUVmax and qPET greater than 11.35 (AUC=0.9, p<0.001) and 4.56 (AUC=0.9, p<0.001) respectively. MTV and TLG thresholds were not able to predict which lesions had no RAI uptake.



CONCLUSIONS: This preliminary work showed that PET/CT, performed concurrently with the first RAI in high-risk DTC patients, could be a promising method to early individuate RAI-refractory DTC patients.


BACKGROUND: ATA Guidelines for adult patients with differentiated thyroid cancer1 (DTC) defined 4 categories to classify radioiodine-refractory patients. 2 out of 4 categories are: presence of metastatic tissue which does not concentrate RAI at the first therapeutic whole-body scan (TxWBS); uptake of radioiodine in some lesions but not in others. Aim of the present study was to evaluate the performance 18F-FDG PET/CT concurrent with first radioiodine therapy (RAI) in high risk differentiated thyroid cancer (DTC) patients to predict radioiodine-refractory DTC distant metastases.



METHODS: We prospectively selected patients classified as high risk by ATA 2015 Risk Stratification System1, submitted to total thyroidectomy and first RAI treatment. 13 patients, off L-T4, were submitted to PET/CT 3 months after surgery and within 1 week from RAI. The analysis of PET/CT and TxWBS images was performed only on distant metastases. Semi-quantitative analysis [standard uptake value (SUV), qPET, metabolic tumor volume (MTV) and total lesion glycolysis (TLG)] was performed on PET/CT target lesions (hottest lesion for each organ). ROC curve analysis was used to identify a potential cut-off for semi-quantitative parameters to predict radioiodine uptake.



RESULTS: To semi-quantitative PET/CT analysis, target lesions with no radioiodine uptake, showed a value of SUVmax and qPET greater than 11.35 (AUC=0.9, p<0.001) and 4.56 (AUC=0.9, p<0.001) respectively. MTV and TLG thresholds were not able to predict which lesions had no RAI uptake.



CONCLUSIONS: This preliminary work showed that PET/CT, performed concurrently with the first RAI in high-risk DTC patients, could be a promising method to early individuate RAI-refractory DTC patients.


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings